|
Volumn 10, Issue 6, 2003, Pages 409-414
|
Calcium antagonists and atherosclerosis protection in hypertension.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTIHYPERTENSIVE AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
LOW DENSITY LIPOPROTEIN;
VASODILATOR AGENT;
ANIMAL;
ARTERIOSCLEROSIS;
CLINICAL TRIAL;
CORONARY ARTERY ATHEROSCLEROSIS;
DOSE RESPONSE;
DRUG EFFECT;
HUMAN;
HYPERTENSION;
METABOLISM;
PATHOLOGY;
PATHOPHYSIOLOGY;
REVIEW;
RISK FACTOR;
VASCULAR ENDOTHELIUM;
VASCULAR SMOOTH MUSCLE;
ANIMALS;
ANTI-ARRHYTHMIA AGENTS;
ANTIHYPERTENSIVE AGENTS;
ARTERIOSCLEROSIS;
CALCIUM CHANNEL BLOCKERS;
CLINICAL TRIALS;
CORONARY ARTERIOSCLEROSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIUM, VASCULAR;
HUMANS;
HYPERTENSION;
LIPOPROTEINS, LDL;
MUSCLE, SMOOTH, VASCULAR;
RISK FACTORS;
VASODILATOR AGENTS;
MLCS;
MLOWN;
|
EID: 2142640369
PISSN: 10752765
EISSN: None
Source Type: Journal
DOI: 10.1097/00045391-200311000-00006 Document Type: Review |
Times cited : (55)
|
References (33)
|